Found 461 chains in Knotted chains table. Displaying 151 - 300. Applied filters: Probabilistic

Search results query: topological notation: S +31 3x +31

Hide raw data panel 
#pdbid|chain|deposition date|is S/K-not|(slip)knot types;
      
  6ymb|A|2020-08-23|S|+3.1;
  6ufd|A|2020-08-22|S|+3.1;
  6ufb|A|2020-08-22|S|+3.1;
  6ufc|A|2020-08-22|S|+3.1;
  6klz|A|2020-08-20|S|+3.1;
  6km0|A|2020-08-20|S|+3.1;
  6km4|A|2020-08-20|S|+3.1;
  6km6|A|2020-08-20|S|+3.1;
  6wq4|A|2020-08-06|S|+3.1;
  6wq8|A|2020-08-06|S|+3.1;
  6wq9|A|2020-08-06|S|+3.1;
  6t7u|A|2020-08-05|S|+3.1;
  6t9z|A|2020-08-05|S|+3.1;
  6rmx|A|2020-08-05|S|+3.1;
  6otk|A|2020-08-04|S|+3.1;
  6oto|A|2020-08-04|S|+3.1;
  6otq|A|2020-08-04|S|+3.1;
  6oub|A|2020-08-04|S|+3.1;
  6otp|A|2020-08-04|S|+3.1;
  6ouh|A|2020-08-04|S|+3.1;
  6oud|A|2020-08-04|S|+3.1;
  6ouf|A|2020-08-04|S|+3.1;
  6ouk|A|2020-08-04|S|+3.1;
  6oui|A|2020-08-04|S|+3.1;
  6ouj|A|2020-08-04|S|+3.1;
  6oum|A|2020-08-04|S|+3.1;
  6rg3|A|2020-08-04|S|+3.1;
  6rmy|A|2020-08-04|S|+3.1;
  6rhk|A|2020-08-04|S|+3.1;
  6rzx|A|2020-08-04|S|+3.1;
  6s03|A|2020-08-04|S|+3.1;
  6sds|A|2020-08-04|S|+3.1;
  6r6j|A|2020-04-17|S|+3.1;
  6r71|A|2020-04-17|S|+3.1;
  6rm1|A|2020-04-17|S|+3.1;
  6qut|A|2020-04-07|S|+3.1;
  6vkg|A|2020-04-02|S|+3.1;
  6ugp|A|2020-03-31|S|+3.1;
  6ugq|A|2020-03-31|S|+3.1;
  6ugr|A|2020-03-31|S|+3.1;
  6ugz|A|2020-03-31|S|+3.1;
  6ugo|A|2020-03-31|S|+3.1;
  6uh0|A|2020-03-31|S|+3.1;
  6r6f|A|2020-03-30|S|+3.1;
  6qn0|A|2020-03-08|S|+3.1;
  6qn2|A|2020-03-08|S|+3.1;
  6qn6|A|2020-03-08|S|+3.1;
  6u4q|A|2020-01-29|S|+3.1;
  6u4t|A|2020-01-29|S|+3.1;
  6nm0|A|2020-01-22|S|+3.1;
  6nlv|A|2020-01-22|S|+3.1;
  6i0l|A|2019-11-27|S|+3.1;
  6nj3|A|2019-10-17|S|+3.1;
  6nj6|A|2019-10-17|S|+3.1;
  6ql2|A|2019-10-16|S|+3.1;
  6ql1|A|2019-10-16|S|+3.1;
  6hd2|A|2019-09-11|S|+3.1;
  6gxb|A|2019-05-15|S|+3.1;
  6gxe|A|2019-05-15|S|+3.1;
  6qfw|A|2019-04-25|S|+3.1;
  6qfu|A|2019-04-25|S|+3.1;
  6qfv|A|2019-04-25|S|+3.1;
  6qfx|A|2019-04-25|S|+3.1;
  6mby|A|2019-03-20|S|+3.1;
  6g6t|A|2019-03-20|S|+3.1;
  6g5u|A|2019-03-20|S|+3.1;
  6g5l|A|2019-03-20|S|+3.1;
  6g7a|A|2019-03-20|S|+3.1;
  6mbv|A|2019-03-20|S|+3.1;
  6qeb|A|2019-03-08|S|+3.1;
  6fjj|A|2019-03-06|S|+3.1;
  6fji|A|2019-03-06|S|+3.1;
  6gcy|A|2019-03-06|S|+3.1;
  6h6s|A|2019-01-16|S|+3.1;
  6hwz|A|2019-01-09|S|+3.1;
  6hx5|A|2019-01-09|S|+3.1;
  6h33|A|2019-01-08|S|+3.1;
  6h34|A|2019-01-08|S|+3.1;
  6g3q|A|2018-12-02|S|+3.1;
  6g3v|A|2018-12-02|S|+3.1;
  6eeo|A|2018-12-02|S|+3.1;
  6ecz|A|2018-12-02|S|+3.1;
  6eeh|A|2018-12-02|S|+3.1;
  6ebe|A|2018-12-02|S|+3.1;
  4ygl|A|2018-10-21|S|+3.1;
  1ttm|A|2018-10-21|S|+3.1;
  1azm|A|2018-10-21|S|+3.1;
  5nea|A|2018-10-21|S|+3.1;
  6b59|A|2018-10-21|S|+3.1;
  5e2m|A|2018-10-21|S|+3.1;
  4qsj|A|2018-10-21|S|+3.1;
  1rzb|A|2018-10-21|S|+3.1;
  5ohh|A|2018-10-21|S|+3.1;
  5n25|A|2018-10-21|S|+3.1;
  4qiz|A|2018-10-21|S|+3.1;
  6evr|A|2018-10-21|S|+3.1;
  4cnv|A|2018-10-20|S|+3.1;
  4bcw|A|2018-10-20|S|+3.1;
  3s75|B|2018-10-20|S|+3.1;
  3dc3|A|2018-10-20|S|+3.1;
  1th9|A|2018-10-20|S|+3.1;
  4gl1|X|2018-10-20|S|+3.1;
  6fe2|A|2018-10-20|S|+3.1;
  4z0q|A|2018-10-20|S|+3.1;
  4qj0|A|2018-10-20|S|+3.1;
  4qk2|A|2018-10-20|S|+3.1;
  4bf1|A|2018-10-20|S|+3.1;
  3d92|A|2018-10-20|S|+3.1;
  2f14|A|2018-10-20|S|+3.1;
  5ogj|A|2018-10-20|S|+3.1;
  5nee|A|2018-10-20|S|+3.1;
  5ljq|A|2018-10-20|S|+3.1;
  4n0x|B|2018-10-20|S|+3.1;
  3mna|A|2018-10-20|S|+3.1;
  4knj|A|2018-10-20|S|+3.1;
  5bu6|A|2018-10-20|S|+3.1;
  4k0z|A|2018-10-20|S|+3.1;
  5fnl|A|2018-10-20|S|+3.1;
  5ehe|A|2018-10-20|S|+3.1;
  1j9w|A|2018-10-20|S|+3.1;
  3mzc|A|2018-10-20|S|+3.1;
  4k0s|A|2018-10-20|S|+3.1;
  5clu|A|2018-10-20|S|+3.1;
  4k0t|A|2018-10-20|S|+3.1;
  3w6h|A|2018-10-20|S|+3.1;
  5fnh|A|2018-10-20|S|+3.1;
  6eki|A|2018-10-20|S|+3.1;
  3igp|A|2018-10-20|S|+3.1;
  5ogp|A|2018-10-20|S|+3.1;
  4xix|A|2018-10-20|S|+3.1;
  4q09|A|2018-10-20|S|+3.1;
  4e3h|A|2018-10-20|S|+3.1;
  4m2w|A|2018-10-20|S|+3.1;
  4q08|A|2018-10-20|S|+3.1;
  4q07|A|2018-10-20|S|+3.1;
  3r17|B|2018-10-20|S|+3.1;
  2cbd|A|2018-10-20|S|+3.1;
  3f4x|A|2018-10-20|S|+3.1;
  2weh|A|2018-10-20|S|+3.1;
  2nnv|A|2018-10-20|S|+3.1;
  2fw4|A|2018-10-20|S|+3.1;
  3dc9|A|2018-10-20|S|+3.1;
  1zsc|A|2018-10-20|S|+3.1;
  2cba|A|2018-10-20|S|+3.1;
  1rj5|A|2018-10-20|S|+3.1;
  2eu3|A|2018-10-20|S|+3.1;
  3mnk|A|2018-10-20|S|+3.1;
  5jep|B|2018-10-20|S|+3.1;
  4qk3|A|2018-10-20|S|+3.1;
  5ekh|A|2018-10-20|S|+3.1;
  5eh5|A|2018-10-20|S|+3.1;
  4rn4|A|2018-10-20|S|+3.1;
  4pq7|A|2018-10-20|S|+3.1;
  3hlj|A|2018-10-20|S|+3.1;
  3oik|A|2018-10-20|S|+3.1;
  3mnj|A|2018-10-20|S|+3.1;
  2x7s|A|2018-10-20|S|+3.1;
  1hcb|A|2018-10-20|S|+3.1;
  3mni|A|2018-10-20|S|+3.1;
  2nng|A|2018-10-20|S|+3.1;
  6b5a|A|2018-10-20|S|+3.1;
  3w6i|A|2018-10-20|S|+3.1;
  2foq|A|2018-10-20|S|+3.1;
  5bu6|B|2018-10-20|S|+3.1;
  4q49|A|2018-10-20|S|+3.1;
  1yo0|A|2018-10-20|S|+3.1;
  4zwz|A|2018-10-20|S|+3.1;
  3ryv|B|2018-10-20|S|+3.1;
  4g7a|A|2018-10-20|S|+3.1;
  5txy|A|2018-10-20|S|+3.1;
  1te3|X|2018-10-20|S|+3.1;
  4k13|A|2018-10-20|S|+3.1;
  1hug|A|2018-10-20|S|+3.1;
  3rz1|B|2018-10-20|S|+3.1;
  3fe4|A|2018-10-20|S|+3.1;
  3bl1|A|2018-10-20|S|+3.1;
  3p44|A|2018-10-20|S|+3.1;
  4z1n|A|2018-10-20|S|+3.1;
  1lgd|A|2018-10-20|S|+3.1;
  1huh|A|2018-10-20|S|+3.1;
  5fnj|A|2018-10-20|S|+3.1;
  6equ|A|2018-10-20|S|+3.1;
  3mwo|A|2018-10-20|S|+3.1;
  5e2s|A|2018-10-20|S|+3.1;
  1cvb|A|2018-10-20|S|+3.1;
  4pyy|A|2018-10-20|S|+3.1;
  4dz7|A|2018-10-19|S|+3.1;
  4hey|A|2018-10-19|S|+3.1;
  2cab|A|2018-10-19|S|+3.1;
  5ehv|A|2018-10-19|S|+3.1;
  2vva|X|2018-10-19|S|+3.1;
  1bzm|A|2018-10-19|S|+3.1;
  4q6d|A|2018-10-19|S|+3.1;
  5aml|A|2018-10-19|S|+3.1;
  5eh8|A|2018-10-19|S|+3.1;
  5e2n|A|2018-10-19|S|+3.1;
  3dcs|A|2018-10-19|S|+3.1;
  5fl6|A|2018-10-19|S|+3.1;
  4lhi|A|2018-10-19|S|+3.1;
  3oyq|A|2018-10-19|S|+3.1;
  1eou|A|2018-10-19|S|+3.1;
  4zao|A|2018-10-19|S|+3.1;
  1oq5|A|2018-10-19|S|+3.1;
  5fni|A|2018-10-19|S|+3.1;
  4r5b|A|2018-10-19|S|+3.1;
  1ray|A|2018-10-19|S|+3.1;
  1cai|A|2018-10-19|S|+3.1;
  3m5t|A|2018-10-19|S|+3.1;
  4pxx|A|2018-10-19|S|+3.1;
  4e3d|A|2018-10-19|S|+3.1;
  3n2p|A|2018-10-19|S|+3.1;
  3t5z|A|2018-10-19|S|+3.1;
  1dcb|A|2018-10-19|S|+3.1;
  3s9t|A|2018-10-19|S|+3.1;
  6bcc|A|2018-10-19|S|+3.1;
  5dsj|A|2018-10-19|S|+3.1;
  5ti0|A|2018-10-19|S|+3.1;
  3hkq|A|2018-10-19|S|+3.1;
  5jn7|A|2018-10-19|S|+3.1;
  4qjw|A|2018-10-19|S|+3.1;
  1cay|A|2018-10-19|S|+3.1;
  4qsi|A|2018-10-19|S|+3.1;
  3sap|A|2018-10-19|S|+3.1;
  4qtl|A|2018-10-19|S|+3.1;
  3m2z|A|2018-10-19|S|+3.1;
  3p5l|A|2018-10-19|S|+3.1;
  4kni|A|2018-10-19|S|+3.1;
  5jg5|B|2018-10-19|S|+3.1;
  3sbh|A|2018-10-19|S|+3.1;
  1cal|A|2018-10-19|S|+3.1;
  5jn1|A|2018-10-19|S|+3.1;
  3ks3|A|2018-10-19|S|+3.1;
  4cnr|A|2018-10-19|S|+3.1;
  3mmf|A|2018-10-19|S|+3.1;
  3s71|B|2018-10-19|S|+3.1;
  3dcw|A|2018-10-19|S|+3.1;
  4idr|X|2018-10-19|S|+3.1;
  3hs4|A|2018-10-19|S|+3.1;
  6cjv|A|2018-10-19|S|+3.1;
  4rux|A|2018-10-19|S|+3.1;
  5jgt|B|2018-10-19|S|+3.1;
  5dsi|A|2018-10-19|S|+3.1;
  1rj6|A|2018-10-19|S|+3.1;
  5llc|A|2018-10-19|S|+3.1;
  3dd0|A|2018-10-19|S|+3.1;
  4mo8|A|2018-10-19|S|+3.1;
  3s78|B|2018-10-19|S|+3.1;
  3v3j|A|2018-10-19|S|+3.1;
  1g6v|A|2018-10-19|S|+3.1;
  2it4|A|2018-10-19|S|+3.1;
  5a6h|A|2018-10-19|S|+3.1;
  4g0c|A|2018-10-19|S|+3.1;
  5u0d|A|2018-10-19|S|+3.1;
  1v9i|C|2018-10-19|S|+3.1;
  1h9n|A|2018-10-19|S|+3.1;
  3dvd|A|2018-10-19|S|+3.1;
  4zx1|A|2018-10-19|S|+3.1;
  3hku|A|2018-10-19|S|+3.1;
  4ito|A|2018-10-19|S|+3.1;
  3v3h|B|2018-10-19|S|+3.1;
  5bnl|A|2018-10-19|S|+3.1;
  4ilx|A|2018-10-19|S|+3.1;
  2pov|A|2018-10-19|S|+3.1;
  5n1r|A|2018-10-19|S|+3.1;
  5jq0|A|2018-10-19|S|+3.1;
  2fmz|A|2018-10-19|S|+3.1;
  5cac|A|2018-10-19|S|+3.1;
  5flq|A|2018-10-19|S|+3.1;
  1t9n|A|2018-10-19|S|+3.1;
  5o07|A|2018-10-19|S|+3.1;
  3qyk|A|2018-10-19|S|+3.1;
  5n1s|A|2018-10-19|S|+3.1;
  5e2r|A|2018-10-19|S|+3.1;
  1caz|A|2018-10-19|S|+3.1;
  4rh2|A|2018-10-19|S|+3.1;
  1xq0|A|2018-10-19|S|+3.1;
  1fqr|A|2018-10-19|S|+3.1;
  5a25|A|2018-10-19|S|+3.1;
  3ni5|A|2018-10-19|S|+3.1;
  3k7k|A|2018-10-19|S|+3.1;
  1fr4|A|2018-10-19|S|+3.1;
  1cah|A|2018-10-19|S|+3.1;
  5jmz|A|2018-10-19|S|+3.1;
  3v3i|B|2018-10-19|S|+3.1;
  5amg|A|2018-10-19|S|+3.1;
  1uga|A|2018-10-19|S|+3.1;
  4hu1|A|2018-10-19|S|+3.1;
  5e2k|A|2018-10-19|S|+3.1;
  1zsb|A|2018-10-19|S|+3.1;
  4n16|A|2018-10-19|S|+3.1;
  3t82|A|2018-10-19|S|+3.1;
  4jsz|A|2018-10-19|S|+3.1;
  3k2f|A|2018-10-18|S|+3.1;
  3kig|A|2018-10-18|S|+3.1;
  3d9z|A|2018-10-18|S|+3.1;
  2q38|A|2018-10-18|S|+3.1;
  2osm|A|2018-10-18|S|+3.1;
  2nmx|A|2018-10-18|S|+3.1;
  3rld|A|2018-10-18|S|+3.1;
  6g9u|A|2018-10-18|S|+3.1;
  5wgp|A|2018-10-18|S|+3.1;
  5fl4|A|2018-10-18|S|+3.1;
  5ekj|A|2018-10-18|S|+3.1;
  4zwi|A|2018-10-18|S|+3.1;
  4zwy|A|2018-10-18|S|+3.1;
  3tvo|X|2018-10-18|S|+3.1;
  4jsw|A|2018-10-18|S|+3.1;
  3t83|A|2018-10-18|S|+3.1;
  4hf3|A|2018-10-18|S|+3.1;
  3lxe|A|2018-10-18|S|+3.1;
  3u7c|A|2018-10-18|S|+3.1;
  3u45|X|2018-10-18|S|+3.1;
  1xpz|A|2018-10-18|S|+3.1;
  3hkt|A|2018-10-18|S|+3.1;
  3p4v|A|2018-10-18|S|+3.1;
  3l14|A|2018-10-18|S|+3.1;
  1ugb|A|2018-10-18|S|+3.1;
  3oil|A|2018-10-18|S|+3.1;
  3dvc|A|2018-10-18|S|+3.1;
  1cnc|A|2018-10-18|S|+3.1;
  1lg6|A|2018-10-18|S|+3.1;
  3v3g|B|2018-10-18|S|+3.1;
  3hfp|A|2018-10-18|S|+3.1;
  2nn1|A|2018-10-18|S|+3.1;
  5dsm|A|2018-10-18|S|+3.1;
  5dsl|A|2018-10-18|S|+3.1;
  4m2v|A|2018-10-18|S|+3.1;
  3s77|B|2018-10-18|S|+3.1;
  5yui|A|2018-10-18|S|+3.1;
  5n0e|A|2018-10-18|S|+3.1;
  5llh|A|2018-10-18|S|+3.1;
  6d1m|A|2018-10-18|S|+3.1;
  1cvd|A|2018-10-18|S|+3.1;
  3m1w|A|2018-10-18|S|+3.1;
  5fng|A|2018-10-18|S|+3.1;
  3uyq|A|2018-10-18|S|+3.1;
  3m5s|A|2018-10-18|S|+3.1;
  2weo|A|2018-10-18|S|+3.1;
  2nn7|A|2018-10-18|S|+3.1;
  5ogo|A|2018-10-18|S|+3.1;
  4xfw|A|2018-10-18|S|+3.1;
  4zwx|A|2018-10-18|S|+3.1;
  4xiw|A|2018-10-18|S|+3.1;
  4riu|A|2018-10-18|S|+3.1;
  4cq0|A|2018-10-18|S|+3.1;
  4cnx|A|2018-10-18|S|+3.1;
  3dcc|A|2018-10-18|S|+3.1;
  1flj|A|2018-10-18|S|+3.1;
  2aw1|A|2018-10-18|S|+3.1;
  1crm|A|2018-10-18|S|+3.1;
  1fr7|A|2018-10-18|S|+3.1;
  3mnh|A|2018-10-18|S|+3.1;
  3p58|A|2018-10-18|S|+3.1;
  6bc9|A|2018-10-18|S|+3.1;
  5wg7|A|2018-10-18|S|+3.1;
  5mjn|A|2018-10-18|S|+3.1;
  5jg3|B|2018-10-18|S|+3.1;
  5jeg|B|2018-10-18|S|+3.1;
  5j8z|A|2018-10-18|S|+3.1;
  4y0j|A|2018-10-18|S|+3.1;
  5c8i|A|2018-10-18|S|+3.1;
  4zx0|A|2018-10-18|S|+3.1;
  4rfd|A|2018-10-18|S|+3.1;
  4q0l|A|2018-10-18|S|+3.1;
  4l5w|A|2018-10-18|S|+3.1;
  4cac|A|2018-10-18|S|+3.1;
  3tvn|X|2018-10-18|S|+3.1;
  4hez|A|2018-10-18|S|+3.1;
  3rg3|A|2018-10-18|S|+3.1;
  3t84|A|2018-10-18|S|+3.1;
  3oim|A|2018-10-18|S|+3.1;
  3rg4|A|2018-10-18|S|+3.1;
  3rge|A|2018-10-18|S|+3.1;
  3p3h|A|2018-10-18|S|+3.1;
  3oy0|A|2018-10-18|S|+3.1;
  2nxr|A|2018-10-18|S|+3.1;
  1tg3|A|2018-10-18|S|+3.1;
  2nxs|A|2018-10-18|S|+3.1;
  1yo1|A|2018-10-18|S|+3.1;
  1cvc|A|2018-10-18|S|+3.1;
  1hec|A|2018-10-18|S|+3.1;
  1teu|X|2018-10-18|S|+3.1;
  1tg9|A|2018-10-18|S|+3.1;
  1lzv|A|2018-10-18|S|+3.1;
  1rze|A|2018-10-18|S|+3.1;
  1kwr|A|2018-10-18|S|+3.1;
  1caj|A|2018-10-18|S|+3.1;
  6b4d|A|2018-10-18|S|+3.1;
  1cam|A|2018-10-18|S|+3.1;
  1cva|A|2018-10-18|S|+3.1;
  5n0d|A|2018-10-18|S|+3.1;
  5zxw|A|2018-10-18|S|+3.1;
  5lla|A|2018-10-18|S|+3.1;
  5ll5|A|2018-10-18|S|+3.1;
  5gmm|A|2018-10-18|S|+3.1;
  5e28|A|2018-10-18|S|+3.1;
  4yvy|A|2018-10-18|S|+3.1;
  4qjx|A|2018-10-17|S|+3.1;
  4knm|A|2018-10-17|S|+3.1;
  4kuw|A|2018-10-17|S|+3.1;
  3n4b|A|2018-10-17|S|+3.1;
  3mdz|A|2018-10-17|S|+3.1;
  1xeg|A|2018-10-17|S|+3.1;
  4qiy|A|2018-10-17|S|+3.1;
  4pzh|A|2018-10-17|S|+3.1;
  4q6e|A|2018-10-17|S|+3.1;
  4ht0|A|2018-10-17|S|+3.1;
  1ccu|A|2018-10-17|S|+3.1;
  3n3j|A|2018-10-17|S|+3.1;
  4ruy|A|2018-10-17|S|+3.1;
  6fag|A|2018-10-12|S|+3.1;
  6ex1|A|2018-10-12|S|+3.1;
  6faf|A|2018-10-12|S|+3.1;
  6f3b|A|2018-10-12|S|+3.1;
  2nwp|A|2018-10-05|S|+3.1;
  1h4n|A|2018-10-05|S|+3.1;
  3pjj|A|2018-10-04|S|+3.1;
  2nwy|A|2018-10-03|S|+3.1;
  1ca2|A|2018-10-03|S|+3.1;
  4kv0|A|2018-10-03|S|+3.1;
  4qjo|A|2018-10-03|S|+3.1;
  4qjp|A|2018-10-03|S|+3.1;
  4hba|A|2018-10-03|S|+3.1;
  4l5u|A|2018-10-03|S|+3.1;
  4kuv|A|2018-10-03|S|+3.1;
  5n24|A|2018-10-03|S|+3.1;
  4rfc|A|2018-10-03|S|+3.1;
  5sz6|A|2018-10-03|S|+3.1;
  4e49|A|2018-10-03|S|+3.1;
  2fou|A|2018-10-03|S|+3.1;
  2cbb|A|2018-10-03|S|+3.1;
  1jd0|A|2018-10-03|S|+3.1;
  3tmj|A|2018-10-02|S|+3.1;
  3b4f|A|2018-10-02|S|+3.1;
  3efi|A|2018-10-01|S|+3.1;
  3dbu|A|2018-10-01|S|+3.1;
  3kok|A|2018-10-01|S|+3.1;
  3eft|A|2018-10-01|S|+3.1;
  2weg|A|2018-10-01|S|+3.1;
  3ffp|X|2018-10-01|S|+3.1;
  3v5g|A|2018-10-01|S|+3.1;
  4cnw|A|2018-10-01|S|+3.1;
  3d0n|A|2018-10-01|S|+3.1;
  6h29|A|2018-09-30|S|+3.1;
  1bcd|A|2018-09-29|S|+3.1;
  1rza|A|2018-09-29|S|+3.1;
  1rzc|A|2018-09-29|S|+3.1;
  1rzd|A|2018-09-29|S|+3.1;
  1lg5|A|2018-09-29|S|+3.1;
  1tbt|X|2018-09-28|S|+3.1;
  1yo2|A|2018-09-28|S|+3.1;
  3d8w|A|2018-09-28|S|+3.1;
  3dd8|A|2018-09-28|S|+3.1;
  2wd2|A|2018-09-28|S|+3.1;
  2x7u|A|2018-09-28|S|+3.1;
  3pyk|A|2018-09-28|S|+3.1;
  3u47|A|2018-09-28|S|+3.1;
  4riv|A|2018-09-27|S|+3.1;
  5dsn|A|2018-09-26|S|+3.1;
  5dsk|A|2018-09-26|S|+3.1;
  5ljt|A|2018-09-26|S|+3.1;
Knot types Knot loop types pdb Title
S +31 S 3x +31 5eh5A Human carbonic anhydrase ii in complex with ligand
S +31 S 3x +31 4rn4A Human carbonic anhydrases ii in complex with a acetazolamide derivative comprising one hydrophobic and one hydrophilic tail moiety
S +31 S 3x +31 4pq7A The crystal structure of the human carbonic anhydrase ii in complex with a sulfamide inhibitor
S +31 S 3x +31 3hljA Crystal structure of human carbonic anhydrase isozyme ii with 3-methylthiobenzimidazo[1,2-c][1,2,3]thiadiazol-7-sulfonamide
S +31 S 3x +31 3oikA Human carbonic anhydrase ii mutant a65s, n67q (ca ix mimic) bound by 2-ethylestradiol 3,17-o,o-bis-sulfamate
S +31 S 3x +31 3mnjA Human carbonic anhydrase ii mutant k170e
S +31 S 3x +31
4
2x7sA Structures of human carbonic anhydrase ii inhibitor complexes reveal a second binding site for steroidal and non-steroidal inhibitors.
S +31 S 3x +31 1hcbA Enzyme-substrate interactions: structure of human carbonic anhydrase i complexed with bicarbonate
S +31 S 3x +31 3mniA Human carbonic anhydrase ii mutant k170d
S +31 S 3x +31
4
2nngA Structure of inhibitor binding to carbonic anhydrase ii
S +31 S 3x +31 6b5aA Carbonic anhydrase ix-mimic in complex with nitrogenous base-bearing benezenesulfonamide
S +31 S 3x +31 3w6iA Crystal structure of 19f probe-labeled hcai
S +31 S 3x +31
4
2foqA Human carbonic anhydrase ii complexed with two-prong inhibitors
S +31 S 3x +31 5bu6B Structure of bpsb deaceylase domain from bordetella bronchiseptica
S +31 S 3x +31 4q49A Room temperature neutron crystal structure of apo human carbonic anhydrase at ph 7.5
S +31 S 3x +31 1yo0A Proton transfer from his200 in human carbonic anhydrase ii
S +31 S 3x +31 4zwzA Engineered carbonic anhydrase ix mimic in complex with a glucosyl sulfamate inhibitor
S +31 S 3x +31 3ryvB Carbonic anhydrase complexed with n-ethyl-4-sulfamoylbenzamide
S +31 S 3x +31 4g7aA The crystal structure of an alpha carbonic anhydrase from the extremophilic bacterium sulfurihydrogenibium yellowstonense yo3aop1
S +31 S 3x +31 5txyA Identification of a new zinc binding chemotype of by fragment screening on human carbonic anhydrase
S +31 S 3x +31 1te3X Effect of shuttle location and ph environment on h+ transfer in human carbonic anhydrase ii
S +31 S 3x +31 4k13A Structure of hcaix mimic (hcaii with 5 mutations in active site) in complex with dorzolamide
S +31 S 3x +31 1hugA Differences in anionic inhibition of human carbonic anhydrase i revealed from the structures of iodide and gold cyanide inhibitor complexes
S +31 S 3x +31 3rz1B Fluoroalkyl and alkyl chains have similar hydrophobicities in binding to the hydrophobic wall of carbonic anhydrase
S +31 S 3x +31
4
3fe4A Crystal structure of human carbonic anhydrase vi
S +31 S 3x +31 3bl1A Carbonic anhydrase inhibitors. sulfonamide diuretics revisited old leads for new applications
S +31 S 3x +31 3p44A Human carbonic anhydrase ii in complex with p-(4-ruthenocenyl-1h-1,2,3-triazol-1-yl)benzenesulfonamide
S +31 S 3x +31 4z1nA Carbonic anhydrase inhibitors: design and synthesis of new heteroaryl-n-carbonylbenzenesulfonamides targeting druggable human carbonic anhydrase isoforms (hca vii, hca ix, and hca xiv)
S +31 S 3x +31 1lgdA Crystal structure analysis of hca ii mutant t199p in complex with bicarbonate
S +31 S 3x +31 1huhA Differences in anionic inhibition of human carbonic anhydrase i revealed from the structures of iodide and gold cyanide inhibitor complexes
S +31 S 3x +31 5fnjA Native state mass spectrometry, surface plasmon resonance and x-ray crystallography correlate strongly as a fragment screening combination
S +31 S 3x +31 6equA X-ray crystal structure of the human carbonic anhydrase ii adduct with a membrane-impermeant inhibitor
S +31 S 3x +31 3mwoA Human carbonic anhydrase ii in a doubled monoclinic cell: a re-determination
S +31 S 3x +31 5e2sA Crystal structure of human carbonic anhydrase ii in complex with the 4-(2-iso-propylphenyl)benzenesulfonamide inhibitor
S +31 S 3x +31 1cvbA Structural and functional importance of a conserved hydrogen bond network in human carbonic anhydrase ii
S +31 S 3x +31 4pyyA Crystal structure of human carbonic anhydrase isozyme ii with inhibitor
S +31 S 3x +31 4dz7A Hca ii in complex with novel sulfonamide inhibitors set d
S +31 S 3x +31 4heyA Activity enhancers of h64a variant of human carbonic anhydrase ii possess multiple binding sites within and around the enzyme structure
S +31 S 3x +31 2cabA Structure, refinement and function of carbonic anhydrase isozymes. refinement of human carbonic anhydrase i
S +31 S 3x +31 5ehvA Human carbonic anhydrase ii in complex with ligand
S +31 S 3x +31 2vvaX Human carbonic anhydrase in complex with co2
S +31 S 3x +31 1bzmA Drug-protein interactions: structure of sulfonamide drug complexed with human carbonic anhydrase i
S +31 S 3x +31 4q6dA Crystal structure of human carbonic anhydrase isozyme ii with 4-[(z)-azepan-1-yldiazenyl]benzenesulfonamide
S +31 S 3x +31 5amlA Three dimensional structure of human carbonic anhydrase ii in complex with 2-(but-2-yn-1-ylsulfamoyl)-4-sulfamoylbenzoic acid
S +31 S 3x +31 5eh8A Human carbonic anhydrase ii in complex with ligand
S +31 S 3x +31 5e2nA Crystal structure of human carbonic anhydrase isozyme xiii with 3-(cyclooctylamino)-2,5,6-trifluoro-4-[(2-hydroxyethyl)sulfonyl]benzenesulfonamide
S +31 S 3x +31 3dcsA Use of carbonic anhydrase ii, ix active-site mimic, for the purpose of screening inhibitors for possible anti-cancer properties
S +31 S 3x +31 5fl6A Three dimensional structure of human carbonic anhydrase ix in complex with 5-(1-(4-methylphenyl)-1h-1,2,3-triazol-4-yl)thiophene-2- sulfonamide
S +31 S 3x +31 4lhiA Crystal structure of human carbonic anhydrase isozyme ii with 5-(phenylsulfonyl)thiophene-2-sulfonamide
S +31 S 3x +31 3oyqA Structure of human carbonic anhydrase ii complexed with 5,6-dihydro-benzo[h]cinnolin-3-ylamine
S +31 S 3x +31 1eouA Crystal structure of human carbonic anhydrase ii complexed with an anticonvulsant sugar sulfamate
S +31 S 3x +31 4zaoA Genetically engineered carbonic anhydrase ix
S +31 S 3x +31 1oq5A Carbonic anhydrase ii in complex with nanomolar inhibitor
S +31 S 3x +31 5fniA Native state mass spectrometry, surface plasmon resonance and x-ray crystallography correlate strongly as a fragment screening combination
S +31 S 3x +31 4r5bA Human carbonic anhydrase ii in complex with a carbohydrate-based sulfamate
S +31 S 3x +31 1rayA The structure of human carbonic anhydrase ii in complex with bromide and azide
S +31 S 3x +31 1caiA Structural analysis of the zinc hydroxide-thr 199-glu 106 hydrogen bonding network in human carbonic anhydrase ii
S +31 S 3x +31 3m5tA Fragment tethered to carbonic anhydrase ii h64c mutant
S +31 S 3x +31 4pxxA Crystal structure of a highly thermal stabilized variant of human carbonic anhydrase ii
S +31 S 3x +31 4e3dA Nucleophile recognition as an alternative inhibition mode for benzoic acid based carbonic anhydrase inhibitors
S +31 S 3x +31 3n2pA Crystal structure of human carbonic anhydrase ii in complex with a benzenesulfonamide inhibitor
S +31 S 3x +31 3t5zA Crystal structure of the human carbonic anhydrase ii in complex with n-methoxy-benzenesulfonamide
S +31 S 3x +31 1dcbA Structure of an engineered metal binding site in human carbonic anhydrase ii reveals the architecture of a regulatory cysteine switch
S +31 S 3x +31 3s9tA Crystal structure of human carbonic anhydrase isozyme ii with 2-chloro-5-{[(4,6-dimethyl-2-pyrimidinyl)sulfanyl]acetyl}benzenesulfonamide
S +31 S 3x +31 6bccA Joint x-ray/neutron structure of human carbonic anhydrase ii in complex with ethoxzolamide
S +31 S 3x +31 5dsjA Structure of co2 released holo-form of human carbonic anhydrase ii with 50 sec warming
S +31 S 3x +31 5ti0A Crystal structure of 2-hydroxycyclohepta-2,4,6-triene-1-thione bound to human carbonic anhydrase 2 l198g
S +31 S 3x +31 3hkqA Human carbonic anhydrase ii in complex with 1-s-d-galactopyranosylsulfonamide
S +31 S 3x +31 5jn7A Carbonic anhydrase ii in complex with u-ch3
S +31 S 3x +31 4qjwA Crystal structure of catalytic domain of human carbonic anhydrase isozyme xii with inhibitor
S +31 S 3x +31 1cayA Wild-type and e106q mutant carbonic anhydrase complexed with acetate
S +31 S 3x +31 4qsiA Crystal structure of human carbonic anhydrase isozyme ii with 5-{[(4-tert-buthyl-6-oxo-1,6-dihydropyrimidin-2-yl)thio]acetyl}-2-chlorobenzenesulfonamide
S +31 S 3x +31 3sapA Crystal structure of human carbonic anhydrase isozyme ii with 4-{[(5-butyl-2-pyrimidinyl)sulfanyl]acetyl}benzenesulfonamide
S +31 S 3x +31 4qtlA Crystal structure of human carbonic anhydrase isozyme ii with inhibitor
S +31 S 3x +31 3m2zA Fragment tethered to carbonic anhydrase ii h64c mutant
S +31 S 3x +31 3p5lA Human carbonic anhydrase complexed with sodium 4-cyano-4-phenylpiperidine-1-carbodithioate
S +31 S 3x +31 4kniA Crystal structure of human carbonic anhydrase isozyme ii with 2-chloro-4-{[(4,6-dimethylpyrimidin-2-yl)sulfanyl]acetyl}benzenesulfonamide
S +31 S 3x +31 5jg5B Human carbonic anhydrase ii (v121t/f131y) complexed with benzo[d]thiazole-2-sulfonamide
S +31 S 3x +31 3sbhA Crystal structure of human carbonic anhydrase isozyme ii with 4-{[(4,6-dimethyl-2-pyrimidinyl)sulfanyl]acetyl}benzenesulfonamide
S +31 S 3x +31 1calA Structural analysis of the zinc hydroxide-thr 199-glu 106 hydrogen bonding network in human carbonic anhydrase ii
S +31 S 3x +31 5jn1A Carbonic anhydrase ix-mimic in complex with u-ch3
S +31 S 3x +31 3ks3A High resolution structure of human carbonic anhydrase ii at 0.9 a
S +31 S 3x +31 4cnrA Surface residue engineering of bovine carbonic anhydrase to an extreme halophilic enzyme for potential application in postcombustion co2 capture
S +31 S 3x +31 3mmfA Crystal structure of human carbonic anhydrase ii in complex with a 1,3,5-triazine-substituted benzenesulfonamide inhibitor
S +31 S 3x +31 3s71B The origin of the hydrophobic effect in the molecular recognition of arylsulfonamides by carbonic anhydrase
S +31 S 3x +31 3dcwA Use of carbonic anhydrase ii, ix active-site mimic, for the purpose of screening inhibitors for possible anti-cancer properties
S +31 S 3x +31 4idrX Human carbonic anhydrase ii proton transfer double mutant
S +31 S 3x +31 3hs4A Human carbonic anhydrase ii complexed with acetazolamide
S +31 S 3x +31 6cjvA Carbonic anhydrase ix-mimic in complex with sucralose
S +31 S 3x +31 4ruxA Crystal structure of human carbonic anhydrase ii in complex with 4-(allyloxy)benzenesulfonamide
S +31 S 3x +31 5jgtB Human carbonic anhydrase ii (f131y/l198a) complexed with 1,3-thiazole-2-sulfonamide
S +31 S 3x +31 5dsiA Structure of co2 bound holo-form of human carbonic anhydrase ii with 0 sec (no) warming
S +31 S 3x +31 1rj6A Crystal structure of the extracellular domain of murine carbonic anhydrase xiv in complex with acetazolamide
S +31 S 3x +31 5llcA Crystal structure of human carbonic anhydrase isozyme ii with 3-(methylamino)-2,5,6-trifluoro-4-[(2-phenylethyl)sulfonyl]benzenesulfonamide
S +31 S 3x +31 3dd0A Use of carbonic anhydrase ii, ix active-site mimic, for the purpose of screening inhibitors for possible anti-cancer properties
S +31 S 3x +31 4mo8A The crystal structure of the human carbonic anhydrase ii in complex with n-[2-(2-methyl-5-nitro-1h-imidazol-1-yl)ethyl]sulfamide
S +31 S 3x +31 3s78B The origin of the hydrophobic effect in the molecular recognition of arylsulfonamides by carbonic anhydrase
S +31 S 3x +31 3v3jA Kinetic and structural studies of thermostabilized mutants of hca ii.
S +31 S 3x +31 1g6vA Complex of the camelid heavy-chain antibody fragment cab-ca05 with bovine carbonic anhydrase
S +31 S 3x +31 2it4A X ray structure of the complex between carbonic anhydrase i and the phosphonate antiviral drug foscarnet
S +31 S 3x +31 5a6hA Synthesis, carbonic anhydrase inhibition and protein x-ray structure of the unusual natural product primary sulfonamide psammaplin c
S +31 S 3x +31 4g0cA Neutron structure of acetazolamide-bound human carbonic anhydrase ii reveal molecular details of drug binding.
S +31 S 3x +31 5u0dA Identification of a new zinc binding chemotype by fragment screening
S +31 S 3x +31 1v9iC Crystal structure analysis of the site specific mutant (q253c) of bovine carbonic anhydrase ii
S +31 S 3x +31 1h9nA H119n carbonic anhydrase ii
S +31 S 3x +31 3dvdA X-ray crystal structure of mutant n62d of human carbonic anhydrase ii
S +31 S 3x +31 4zx1A Engineered carbonic anhydrase ix mimic in complex with a glucosyl sulfamate inhibitor
S +31 S 3x +31 3hkuA Human carbonic anhydrase ii in complex with topiramate
S +31 S 3x +31 4itoA Human ca ii inhibition by novel sulfonamide
S +31 S 3x +31 3v3hB Kinetic and structural studies of thermostabilized mutants of hca ii.
S +31 S 3x +31 5bnlA Deciphering the mechanism of carbonic anhydrase inhibition with coumarins and thiocoumarins
S +31 S 3x +31 4ilxA Structure of human carbonic anhydrase ii in complex with an adamantyl sulfonamide inhibitor
S +31 S 3x +31 2povA The crystal structure of the human carbonic anhydrase ii in complex with 4-amino-6-chloro-benzene-1,3-disulfonamide
S +31 S 3x +31 5n1rA Crystal structure of human carbonic anhydrase ii in complex with the inhibitor 4'-pyrazol-1-ylmethyl-biphenyl-4-sulfonamide
S +31 S 3x +31 5jq0A Crystal structure of human carbonic anhydrase ii in complex with benzoxaborole at ph=8.7
S +31 S 3x +31 2fmzA Carbonic anhydrase activators. activation of isoforms i, ii, iv, va, vii and xiv with l- and d- phenylalanine, structure with d-phenylalanine.
S +31 S 3x +31 5cacA Refined structure of human carbonic anhydrase ii at 2.0 angstroms resolution
S +31 S 3x +31 5flqA Native state mass spectrometry, surface plasmon resonance and x-ray crystallography correlate strongly as a fragment screening combination
S +31 S 3x +31 1t9nA Effect of shuttle location and ph environment on h+ transfer in human carbonic anhydrase ii
S +31 S 3x +31 5o07A The crystal structure of the human carbonic anhydrase ii in complex with a nitroimidazole sulfamate inhibitor
S +31 S 3x +31 3qykA Human carbonic anhydrase ii complexed with triple ring benzene sulfonamide inhibitor
S +31 S 3x +31 5n1sA Crystal structure of human carbonic anhydrase ii in complex with the inhibitor 4-(1h-indol-2-yl)-benzenesulfonamide
S +31 S 3x +31 5e2rA The crystal structure of the human carbonic anhydrase ii in complex with a 1,1'-biphenyl-4-sulfonamide inhibitor
S +31 S 3x +31 1cazA Wild-type and e106q mutant carbonic anhydrase complexed with acetate
S +31 S 3x +31 4rh2A Crystal structure of human carbonic anhydrase ii in complex with 2-(6-hydroxy-3-oxo-3h-xanthen-9-yl)-5-{3-1-(4-sulfamoyl-phenyl)-1h-[1,2,3]triazol-4-ylmethyl-thioureido}-benzoic acid
S +31 S 3x +31 1xq0A Structure of human carbonic anhydrase ii with 4-[(3-bromo-4-o-sulfamoylbenzyl)(4-cyanophenyl)amino]-4h-[1,2,4]-triazole
S +31 S 3x +31 1fqrA X-ray crystal structure of cobalt-bound f93i/f95m/w97v carbonic anhydrase (caii) variant
S +31 S 3x +31 5a25A Rational engineering of a mesophilic carbonic anhydrase to an extreme halotolerant biocatalyst
S +31 S 3x +31 3ni5A Carbonic anhydrase inhibitor: c1 family
S +31 S 3x +31 3k7kA Crystal structure of the complex between carbonic anhydrase ii and anions
S +31 S 3x +31 1fr4A X-ray crystal structure of copper-bound f93i/f95m/w97v carbonic anhydrase (caii) variant
S +31 S 3x +31 1cahA Structure of cobalt carbonic anhydrase complexed with bicarbonate
S +31 S 3x +31 5jmzA Carbonic anhydrase ix-mimic in complex with u-no2
S +31 S 3x +31 3v3iB Kinetic and structural studies of thermostabilized mutants of hca ii.
S +31 S 3x +31 5amgA Three dimensional structure of human carbonic anhydrase ii in complex with 2-(pentylsulfamoyl)-4-sulfamoylbenzoic acid
S +31 S 3x +31 1ugaA Human carbonic anhydrase ii[hcaii] (e.c.4.2.1.1) mutant with ala 65 replaced by phe (a65f)
S +31 S 3x +31 4hu1A Crystal structure of human carbonic anhydrase isozyme xiii with the inhibitor.
S +31 S 3x +31 5e2kA Crystal structure of human carbonic anhydrase ii in complex with the 4-(3-aminophenyl)benzenesulfonamide inhibitor
S +31 S 3x +31 1zsbA Carbonic anhydrase ii mutant e117q, transition state analogue acetazolamide
S +31 S 3x +31 4n16A Structure of cholate bound to human carbonic anhydrase ii
S +31 S 3x +31 3t82A Human carbonic anhydrase ii in complex with acetylated carbohydrate sulfamates
S +31 S 3x +31 4jszA Benzenesulfonamide bound to hcaii h94c
S +31 S 3x +31 3k2fA Nitric oxide-donating carbonic anhydrase inhibitors for the treatment of open-angle glaucoma
S +31 S 3x +31 3kigA Mutant carbonic anhydrase ii in complex with an azide and an alkyne
S +31 S 3x +31 3d9zA Use of carbonic anhydrase ii, ix active-site mimic, for the purpose of screening inhibitors for possible anti-cancer properties
S +31 S 3x +31 2q38A Carbonic anhydrase ii in complex with saccharin at 1.95 angstrom
S +31 S 3x +31 2osmA Inhibition of carbonic anhydrase ii by thioxolone: a mechanistic and structural study
S +31 S 3x +31 2nmxA Structure of inhibitor binding to carbonic anhydrase i
S +31 S 3x +31 3rldA Crystal structure of the y7i mutant of human carbonic anhydrase ii
S +31 S 3x +31 6g9uA Three dimensional structure of human carbonic anhydrase ix in complex with sulfonamide
How to cite
KnotProt | Interdisciplinary Laboratory of Biological Systems Modelling